Trial Profile
Multi center, open label study to evaluate the influence of pioglitazone treatment over 6 months on metabolic control in type II diabetic patients previously treated with insulin
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 17 Sep 2021
Price :
$35
*
At a glance
- Drugs Glimepiride (Primary) ; Pioglitazone (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms PIOswitch
- 10 Jan 2008 New trial record.